Singular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023
26 Juli 2023 - 10:05PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and multiomics
technologies to empower researchers and clinicians, today announced
that it will report financial results for the second quarter 2023
after the market close on Wednesday, August 9, 2023. The company’s
management will discuss the results during a conference call
beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the
conference call may do so by accessing a live and archived webcast
of the event at investor.singulargenomics.com, in the Presentations
& Events section.
About Singular Genomics Systems,
Inc. Singular Genomics is a life science technology
company that develops next-generation sequencing and multiomics
technologies. The commercially available G4 Sequencing Platform is
a powerful, highly versatile benchtop genomic sequencer designed to
produce fast and accurate results. In development, the PX system
leverages Singular’s proprietary sequencing technology, applying it
as an in situ readout to look at RNA and proteins in single cells
and tissue. With these products, Singular Genomics’ mission is to
empower researchers and clinicians to advance science and medicine.
Visit www.singulargenomics.com for more information.
Investor ContactMatt
Clawson949-370-8500ir@singulargenomics.com
Media ContactDan Budwick,
1AB973-271-6085dan@1abmedia.com
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024